![Steve Krognes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steve Krognes
Direktör/Styrelseledamot på
DENALI THERAPEUTICS INC.
Förmögenhet: 21 M $ per 2026-09-30
Profil
Mr. Steve E.
Krognes is an Independent Director at Pliant Therapeutics, Inc., an Independent Non-Executive Director at argenx SE and an Independent Director at Guardant Health, Inc. He is on the Board of Directors at Pliant Therapeutics, Inc., argenx SE, Guardant Health, Inc. and Denali Therapeutics, Inc. Mr. Krognes was previously employed as an Independent Director by Nexoplex Bio, Inc., an Independent Director by Corvus Pharmaceuticals, Inc., a Trustee by The California Academy of Sciences, a CFO, Senior VP, Regional Head-Finance & IT by Genentech, Inc., a Chairman by Genentech Access To Care Foundation, a Head-Mergers & Acquisitions by Roche Holding AG, and a Director-Mergers & Acquisitions by GiroBank A/S.
He also served on the board at Rls Global AB and California Life Sciences Association.
He received his undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from Harvard Business School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
DENALI THERAPEUTICS INC. 0,51 % | 2026-06-03 | 819 999 ( 0,51 % ) | 17 M $ | 2026-09-30 |
ARGENX SE 0 % | 2026-06-30 | 2 637 ( 0 % ) | 3 M $ | 2026-09-30 |
GUARDANT HEALTH, INC. 0,01 % | 2026-09-16 | 7 906 ( 0,01 % ) | 1 M $ | 2026-09-30 |
| 2026-06-11 | 0 ( -.--% ) | - $ | 2026-09-30 |
Aktiva positioner av Steve Krognes
| Företag | Position | Start |
|---|---|---|
| DENALI THERAPEUTICS INC. | Direktör/Styrelseledamot | 2022-05-01 |
| GUARDANT HEALTH, INC. | Direktör/Styrelseledamot | 2022-06-30 |
| ARGENX SE | Direktör/Styrelseledamot | 2023-02-27 |
| PLIANT THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2024-06-13 |
Tidigare kända positioner av Steve Krognes
| Företag | Position | Slut |
|---|---|---|
| GRITSTONE BIO, INC. | Direktör/Styrelseledamot | 2024-06-17 |
| RLS GLOBAL AB (PUBL) | Direktör/Styrelseledamot | 2023-01-01 |
| CORVUS PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2021-06-15 |
The California Academy of Sciences
 The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a scientific and cultural institution | Direktör/Styrelseledamot | 2018-01-01 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Finansdirektör/CFO | 2015-09-01 |
Steve Krogness utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
96
Första gradens relationer
15
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 15 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Guardant Health, Inc.
 Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
Danske Bank A/S
 Danske Bank A/S Major BanksFinance Provides banking services | Finance |
The California Academy of Sciences
The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a scientific and cultural institution | Commercial Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
RLS Global AB
 RLS Global AB BiotechnologyHealth Technology Develops biochemical products | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Genentech Access To Care Foundation |
